Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Change in Receivables (2021 - 2026)

Zymeworks (ZYME) posted Change in Receivables of $36000.0 for Q1 2026, up 100.15% sequentially from -$24.7 million in Q4 2025, and up 100.12% YoY from $17989.6 in Q1 2025.

Analysis

Zymeworks (ZYME) Change in Receivables (2021 - 2026) Analysis & Trends

Zymeworks has reported Change in Receivables for 6 years, with the latest figure at $36000.0 in Q1 2026.

  • Quarterly Change in Receivables rose 100.12% year-over-year to $36000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.9 million (down 215.19% YoY) and the FY2025 annual result came in at -$51.2 million, down 240.82% from the prior year.
  • Change in Receivables advanced to $36000.0 in Q1 2026 per ZYME's latest filing, from -$24.7 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $33.5 million in Q1 2023 and troughed at -$47.8 million in Q4 2023.
  • A 5-year average of -$659882.4 and a median of $36000.0 in 2026 frame the typical range for Change in Receivables.
  • The widest YoY moves for Change in Receivables: up 697.92% in 2023, down 11886.09% in 2023.
  • Over 5 years, Change in Receivables stood at $26.7 million in 2022, then slumped by 279.2% to -$47.8 million in 2023, then soared by 166.18% to $31.6 million in 2024, then plunged by 178.13% to -$24.7 million in 2025, then soared by 100.15% to $36000.0 in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered $36000.0, -$24.7 million, and $26.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 37.16 Mn
10 Zymeworks 2.13 Bn 1.86 Bn - 1.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.26 Mn
Mar 31, 2026 36,000.00
Dec 31, 2025 -24.71 Mn
Sep 30, 2025 26.72 Mn
Jun 30, 2025 -21.99 Mn
Mar 31, 2025 -31.22 Mn
Dec 31, 2024 31.63 Mn
Sep 30, 2024 -7.88 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 11.47 Mn
Dec 31, 2023 -47.80 Mn
Sep 30, 2023 18.46 Mn
Jun 30, 2023 -18.10 Mn
Mar 31, 2023 33.52 Mn
Dec 31, 2022 26.67 Mn
Sep 30, 2022 2.31 Mn
Jun 30, 2022 -151,000.00
Mar 31, 2022 -11.33 Mn
Dec 31, 2021 10.69 Mn